Supplements and Featured Publications
Biopharmaceutical Agents for Treating Rheumatoid Arthritis: Impact on Patients and Managed Care Heal
Volume: 9
Issue: 6 Suppl
Antithrombotic Therapy for the Treatment of Venous Thromboembolism
Volume: 9
Issue: 5 Suppl
Managed Care and Biologic Therapies
Volume: 9
Issue: 4 Suppl
Decision Maker News in Managed Care: Proceedings from the Atlanta Healthcare Summit, Part II
Volume: 9
Issue: 2 Decision
Examining the Dyslipidemia Constellation
Volume: 9
Issue: 1 Dyslipid
Decision Maker News in Managed Care: Proceedings from the Atlanta Healthcare Summit, Part I
Volume: 9
Issue: 1 Decision
Advances in Diabetes Care: Prevention of the Complications of Diabetes
Volume: 9
Issue: 3 Suppl
Effective Management of Patients With Dyslipidemia
Volume: 9
Issue: 2 Suppl
Combination Vaccines: A New Paradigm in Pediatric Immunization Practices
Volume: 9
Issue: 1 Suppl
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
2
Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year
3
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
4
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
5